Notably, patient #A30 was in treatment with anti-PD-1 adjuvant therapy for radically resected stage IIIC melanoma; the BRAF-V600/NRAS analysis was performed on the metastatic sentinel node, and no mutation was found on this tissue. The gene discussed is BRAF; the disease is melanoma.